Evidence map›Paper›PMID 33907494›Full record

ArticleTurkish journal of biology = Turk biyoloji dergisi2021

Detailed evaluation of cancer sequencing pipelines in different microenvironments and heterogeneity levels.

Batuhan Kısakol, Şahin Sarıhan, Mehmet Arif Ergün, Mehmet Baysan

Abstract read
In one paragraph

Article in Turkish journal of biology = Turk biyoloji dergisi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Batuhan KısakolDepartment of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin Ireland.ORCID https://orcid.org/0000-0002-8732-5216
Şahin SarıhanComputer Engineering Department, Faculty of Engineering, Marmara University, İstanbul, Turkey Turkey.ORCID https://orcid.org/0000-0002-2597-1001
Mehmet Arif ErgünComputer Engineering Department, Faculty of Computer and Informatics Engineering, İstanbul Technical University,İstanbul Turkey.ORCID https://orcid.org/0000-0002-9399-1530
Mehmet BaysanComputer Engineering Department, Faculty of Computer and Informatics Engineering, İstanbul Technical University,İstanbul Turkey.ORCID https://orcid.org/0000-0001-7359-2965

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The importance of next generation sequencing (NGS) rises in cancer research as accessing this key technology becomes easier for researchers. The sequence data created by NGS technologies must be processed by various bioinformatics algorithms within a pipeline in order to convert raw data to meaningful information. Mapping and variant calling are the two main steps of these analysis pipelines, and many algorithms are available for these steps. Therefore, detailed benchmarking of these algorithms in different scenarios is crucial for the efficient utilization of sequencing technologies. In this study, we compared the performance of twelve pipelines (three mapping and four variant discovery algorithms) with recommended settings to capture single nucleotide variants. We observed significant discrepancy in variant calls among tested pipelines for different heterogeneity levels in real and simulated samples with overall high specificity and low sensitivity. Additional to the individual evaluation of pipelines, we also constructed and tested the performance of pipeline combinations. In these analyses, we observed that certain pipelines complement each other much better than others and display superior performance than individual pipelines. This suggests that adhering to a single pipeline is not optimal for cancer sequencing analysis and sample heterogeneity should be considered in algorithm optimization.

Indexed as

cancerClinical bioinformaticsmapping algorithmsnext generation sequencingvariant discovery algorithms

Identifiers

PMID33907494
PMCPMC8068765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.